Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1537
+0.0013 (0.85%)
At close: Oct 2, 2026
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $262.16 million as of October 2, 2026. Its market cap has decreased by -30.66% in one year.
Market Cap
262.16M
Enterprise Value
328.40M
Revenue
2.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
ChartMarket Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 262.16M, an increase of 2,447.87%. That is a compound annual growth rate of 13.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 262.16M | -26.85% |
| Dec 31, 2025 | 358.39M | -1.53% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 658.09M |
| CytoDyn | 285.77M |
| Glorywin Entertainment Group | 234.77M |
| BetterLife Pharma | 119.62M |
| Vaxart | 107.01M |
| Nuo Therapeutics | 60.54M |
| Sangamo Therapeutics | 60.20M |
| NDT Pharmaceuticals | 47.77M |